Antiphospholipid Antibodies,Eicosanoids and Expression of Endothelial Cyclooxygenase-2

Triplett DA . Antiphospholipid antibodies and thrombosis. A consequence coincidence or cause?. Arch Pathol Lab Med 1993; 117: 78–88

Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome. J Rheumatol 1992; 19: 1778–1781

Vermylen J Arnout J . Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?. J Lab Clin Med 1992; 120: 10–12

McNeil HP Simpson RJ Chesterman CN Krilis SA . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β₂-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120–4124

Bevers EM Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostas 1991; 66: 629–632

Roubey RAS . Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other ‘antiphospholipid antibodies‘. Blood 1994; 84: 2854–2867

Matsuura E Anticardiolipin antibodies recognize β₂ glycoprotein I structure altered to interact with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457–462

Ichikawa K β₂ glycoprotein I reactivity to monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994; 37: 453–1461

Arvieux J Roussel B Jacob MC Colomb MG . Measurement of antiphospholipid antibodies by ELISA using β₂-glycoprotein I as an antigen. J Immunol Methods 1991; 143: 223–229

Viard JP Amouia Z Bach JF . Association of anti-β₂ Glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181–186

Martinuzzo ME Forastiero RR Carreras LO . Anti β₂ Glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89: 397–402

Arvieux J Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemostas 1995; 74: 1120–1125

Moncada S Vane JR . Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 1978; 34: 129–135

Carreras LO Recurrent arterial thrombosis, repeated intrauterine death and ‘lupus' anticoagulant. Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244–246

Carreras LO Vermylen JG . ‘Lupus' anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemostas 1982; 48: 38–40

Elias M Eldor A . Thromboembolism in patients with the ‘lupus' type circulating anticoagulant. Arch Intern Med 1984; 144: 510–515

Schorer AE Wickham NWR Watson KV . Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. Br J Haematol 1989; 71: 399–407

Watson KV Schorer AE . Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients. Am J Med 1991; 90: 47–53

Lindsay NJ Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and antiphospholipid syndrome. Br J Haematol 1994; 33: 20–26

Cariou R Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells. Inhibition of thrombomodulin-dependent protein C activation. Thromb Haemostas 1988; 60: 54–58

Petraiuolo W Bovill E Hoak J . The lupus anticoagulant stimulates the release of prostacyclin from human endothelial cells. Thromb Res 1988; 50: 847–855

Carreras LO Maclouf J . The lupus anticoagulant and eicosanoids. Prostaglandins Leukotrienes and Essential Fatty Acids 1993; 49: 483–488

Lellouche F Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 1991; 78: 2894–2899

Lellouche F Falcón C Carreras L Maclouf J . Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low doses aspirin as assessed by enzyme immunoassay. In: Samuelsson B Ramwell PW Paoletti R Folco G Granstrom E (eds) Advances in Prostaglandins, Thromboxane and Leukotrienes Research, Vol. 21. Raven Press: New York, 1990, 611–614

Kaaja R Julkunen H Viinikka L Ylikorkala O . Production of prostacyclin and thromboxane in lupus pregnancies: Effect of small dose of aspirin. Obstet Gynecol 1993; 81: 327–331

Arfors L Vestergvist O Johnsson H Grien K . Increased thromboxane formation in patients with antiphospholipid syndrome. Eur J Clin Invest 1990; 20: 607–612

Violi F Thromboxane biosynthesis in patients with systemic lupus erythematosus. Thromb Haemostas 1993; 69: 541 (abstract)

Schinco PC Lupus anticoagulant: Interference with in vivo prostaglandin production and with platelet sensitivity to prostacyclin. Scand J Rheumatol 1992; 21: 124–128

Hasselaar P Derksen RHWM Blokzijil L de Groot PG . Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis. Thromb Haemostas 1988; 59: 80–85

Lin YL Wang CT . Activation of human platelets by the rabbit anticardiolipin antibodies. Blood 1992; 80: 3135–3143

Martinuzzo ME Maclouf J Carreras LO Levy Toledano S . Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemostas 1993; 70: 667–671

Peaceman AM Rehnberg KA . The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1993; 169: 1403–1406

Peaceman AM Rehnberg KA . The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant. Am J Obstet Gynecol 1995; 173: 1391–1396

Shoenfeld Y Blank M . Effect of long-acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome. Lupus 1994; 3: 397–400

Habib A Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. Thromb Haemostas 1995; 74: 770–777

Habib A Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the C-terminal region of the cyclooxygenase-2. J Biol Chem 1993; 268: 23448–23454

Kujubu DA TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266: 12866–12872

Moatter T Gerritsen ME . Fibroblast growth factor upregulates PGG/H synthase in rabbit microvascular endothelial cells by a glucocorticoid-independent mechanism. J Cell Physiol 1992; 151: 571–578

Schorer AE Duane PG Woods VL Niewoehner DE . Some antiphospholipid antibodies inhibit phospholipase A₂ activity. J Lab Clin Med 1992; 120: 67–77

Ballou LR Interleukin-1-mediated PGE₂ production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 1992; 267: 20044–20050

Murakami M Matsumoto R Austen KF Arm JP . Prostaglandin endoperoxide synthase-1 and −2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J Biol Chem 1994; 269: 22269–22275

Morita I Different intracellular locations for prostaglandin endoperoxide synthases-1 and −2. J Biol Chem 1995; 270: 10902–10908

De Witt DL Smith WL . Yes, but do they still get headaches?. Cell 1995; 83: 345–348

Tsai AL Sanduja R Wu K . Evidence for two pools of prostaglandin H synthase in human endothelial cells. In: Samuelsson B Ramwell PW Paoletti R Folco G Granstrom E (eds) Advances in Prostaglandins, Thromboxane and Leukotrienes Research, Vol. 21. Raven Press: New York, 1990, pp 141–144

Shi W Chong BH Chesterman CN . β₂ Glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Blood 1993; 81: 1255–1262

Arvieux J Roussel B Pouzol P Colomb G . Platelet activating properties of murine monoclonal antibodies to β₂ Glycoprotein I. Thromb Haemostas 1993; 70: 336–344